Investor relations
Our science-led strategy is key to delivering long-term value for patients, employees and shareholders.
NYSE: MRK
June 25, 2021 8:28 am ET
Delayed at least 20 minutes
Latest news, events & financials
July 29, 2021
October 28, 2021
Merck & Co., Inc. at the Guggenheim Biopharma Strategy Series
Our pipeline shows our relentless pursuit of the next breakthrough.
Phase II programs
38
Phase III programs
22
Under review
5
Our leadership
Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy.
Corporate responsibility
Supporting the future of our business and the health and well-being of patients, people and communities around the world.
